HomeSUPN • NASDAQ
add
Supernus Pharmaceuticals Inc
Previous close
$49.76
Day range
$49.18 - $50.18
Year range
$29.16 - $59.68
Market cap
2.85B USD
Avg Volume
569.05K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 211.57M | 21.48% |
Operating expense | 255.20M | 22.31% |
Net income | -4.10M | -126.78% |
Net profit margin | -1.94 | -122.05% |
Earnings per share | 0.88 | 60.88% |
EBITDA | 36.79M | -4.21% |
Effective tax rate | -114.47% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 308.67M | -31.95% |
Total assets | 1.45B | 6.18% |
Total liabilities | 390.93M | 17.63% |
Total equity | 1.06B | — |
Shares outstanding | 57.58M | — |
Price to book | 2.69 | — |
Return on assets | 2.05% | — |
Return on capital | 2.68% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -4.10M | -126.78% |
Cash from operations | 19.86M | -55.27% |
Cash from investing | -51.31M | -306.00% |
Cash from financing | 8.53M | 44.75% |
Net change in cash | -22.92M | -160.87% |
Free cash flow | 26.54M | -42.37% |
About
Founded
2005
Headquarters
Website
Employees
778
